The central nervous system as a reservoir for simian immunodeficiency virus (SIV): Steady-state levels of SIV DNA in brain from acute through asymptomatic infection

Journal of Infectious Diseases

Volumn 186, Issue 7, 2002, Pages 905-913

  Clements, Janice E ^a   Babas, Tahar ^a   Mankowski, Joseph L ^a   Suryanarayana, K ^c   Piatak, Michael ^c   Tarwater, Patrick M ^b   Lifson, Jeffrey D ^c   Zink, M Christine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; MACACA; MACROPHAGE; MICROGLIA; MONKEY DISEASE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; TISSUE DISTRIBUTION; VIRUS DETECTION; VIRUS REPLICATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; CARRIER STATE; DISEASE MODELS, ANIMAL; DNA, VIRAL; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MACACA NEMESTRINA; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE PROTEINS; MICROGLIA; PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0036786355     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/343768     Document Type: Article

References (35)

1. Cinque P, Presi S, Bestetti A, et al. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. AIDS Res Hum Retroviruses 2001; 17:377-83.
2. Cinque P, Bestetti A, Morelli P, Presi S. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system. J Neurovirol 2000; 6(Suppl 1):S95-102.
3. Gisolf EH, Enting RH, Jurriaans S, et al. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine. AIDS 2000; 14:1583-9.
4. Enting RH, Prins JM, Jurriaans S, Brinkman K, Portegies P, Lange JM. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection. Clin Infect Dis 2001; 32:1095-9.
5. Stingele K, Haas J, Zimmermann T, et al. Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology 2001; 56:355-61.
6. Chun TW, Davey RT Jr, Ostrowski M, et al. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 2000; 6:757-61.
7. Garbuglia AR, Zaccarelli M, Calcaterra S, Cappiello G, Marini R, Benedetto A. Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): high viral burden in macrophages after 1 year of treatment. J Chemother 2001; 13:188-94.
8. Lambotte O, Taoufik Y, de Goer MG, Wallon C, Goujard C, Delfraissy JF. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 23:114-9.
9. Crowe SM, Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J Leukoc Biol 2000; 68:345-50.
10. Sonza S, Mutimer HP, Oelrichs R, et al. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 2001; 15:17-22.
11. Zink MC, Suryanarayana K, Mankowski JL, et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999; 73:10480-8.
12. Zink MC, Martin AA, Mankowski JL, et al. Pathogenesis of SIV encephalitis: selection and replication of neurovirulent SIV. Am J Pathol 1997; 151:793-803.
13. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE. Molecular and biological characterization of a neurovirulent molecular clone of SIV. J Virol 1997; 71:5790-8.
14. Mankowski JL, Spelman JP, Ressetar HG, et al. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J Virol 1994; 68:8202-8.
15. Hirsch VM, Fuerst TR, Sutter G, et al. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol 1996; 70:3741-52.
16. Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 1998; 14:183-9.
17. Carter DL, Shieh TM, Blosser RL, et al. CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry 1999; 37:41-50.
18. Gonzalez-Scarano F, Strizki JM, Albright A, Shieh J. Use of primary CNS cultures to investigate HIV neurotropism. J Neurovirol 1997;3(Suppl 1):S11-3.
19. Shieh JT, Martin J, Baltuch G, Malim MH, Gonzalez-Scarano F. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains. J Virol 2000; 74:693-701.
20. Babas T, Vielker E, Hauer DA, et al. Pathogenesis of SIV pneumonia: selective replication of viral genotypes in the lung. Virology 2001; 287:371-81.
21. - T lymphocytes. J Immunol 1990; 144:574-82.
22. Amedee AM, Lacour N, Gierman JL, et al. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol 1995; 69:7982-90.
23. Williams KC, Corey S, Westmoreland SV, et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001; 193:905-15.
24. Davis LE, Hjelle BL, Miller VE. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42:1736-9.
25. Lackner AA, Vogel P, Ramos RA, Kluge JD, Marthas M. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am J Pathol 1994; 145:428-39.
26. Chakrabarti L, Hurtrel M, Maire MA, et al. Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol 1991; 139:1273-80.
27. Hockett RD, Kilby JM, Derdeyn CA, et al. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med 1999; 189:1545-54.
28. O'Brien WA, Namazi M, Kalhor H, Mao SH, Zack JA, Chen ISY. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J Virol 1994; 68:1258-63.
29. Kootstra NA, Schuitemaker H. Proliferation-dependent replication in primary macrophages of macrophage-tropic HIV type 1 variants. AIDS Res Hum Retroviruses 1998; 14:339-45.
30. Kootstra NA, Zwart BM, Schuitemaker H. Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle. J Virol 2000; 74:1712-7.
31. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410:988-94.
32. Smits HA, Boven LA, Pereira CF, Verhoef J, Nottet HS. Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia. Eur J Clin Invest 2000; 30:526-35.
33. Yang X, Chen Y, Gabuzda D. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J Biol Chem 1999; 274:27981-8.
34. + lymphocyte-mediated suppression of human immunodeficiency virus type 1 expression in human brain cells. Immunol Lett 1999; 67:257-61.
35. Lanza F, Moretti S, Papa S, Malvasi F, Castoldi G. Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Haematologica 1994; 79:374-86.